World Dog Federation · Science & Genetics

Institute of Genetic Research and Development

Canine genetics, health, selection and population research brought together in one international framework. The Institute supports evidence-based breeding through verified DNA data, veterinary screening, responsible reproductive classifications and long-term scientific monitoring.

Institute of Genetic Research and Development official identity
Verified biological identityMicrochip, DNA profile, parentage and traceable biological sample.
Breed-specific healthScreening protocols selected according to real risks, not one universal list.
Responsible selectionGenotype, phenotype, pedigree, health and reproductive compatibility evaluated together.
A.I.D.D. population dataIndividual records become long-term international statistics and research evidence.
Institutional mission

Research that protects health without reducing the dog to a single test result

The Institute develops and coordinates WDF projects in canine genetics, hereditary disease prevention, population health, DNA traceability and responsible breeding. Its role is to connect scientific evidence with real breeding decisions, without confusing genetic risk with a veterinary diagnosis and without applying the same test protocol to every breed.

Modern canine selection requires a combination of biological identity, pedigree continuity, clinical and phenotypic screening, validated genetic tests, reproductive history, offspring monitoring and population-level analysis. The objective is progressive risk reduction while preserving genetic diversity and the functional, behavioural and biological integrity of each breed.

This approach is already reflected in WDF project documentation: monogenic disorders, complex or polygenic conditions, penetrance, family history and population diversity must be interpreted together. A negative DNA result excludes only the variants actually tested; it is not a universal certificate of health.

Scientist carrying out laboratory research
Genetic information gains value when laboratory data are connected to phenotype, pedigree, veterinary evidence and population monitoring.
Research areas

The principal fields monitored by the Institute

The following areas describe the scientific scope of the project. Exact tests and thresholds must always remain breed-specific and be interpreted by competent veterinary or laboratory professionals.

DNA

Inherited disorders

Validated molecular tests for breed-relevant hereditary diseases, including clear, carrier and affected genotypes where the inheritance mechanism is known.

ORTHO

Skeletal & orthopaedic health

Hip and elbow dysplasia, patellar luxation, spinal and chondrodystrophy-related risks, developmental orthopaedic conditions and other phenotype-based assessments.

NEURO

Neurologic & neuromuscular conditions

Breed-specific testing and clinical monitoring for degenerative, neuropathic or muscular disorders where validated diagnostic or genetic tools exist.

EYE · EAR

Vision & hearing

Progressive retinal disorders, inherited ocular abnormalities and hearing risks, with ophthalmic or BAER-type screening where appropriate.

CARDIO

Cardiac, endocrine & metabolic health

Breed-relevant cardiac screening, thyroid evaluation and inherited metabolic disorders considered within integrated veterinary protocols.

BLOOD

Haematology, coagulation & immune risk

Inherited bleeding disorders, blood-cell abnormalities and selected immune-mediated predispositions considered when validated tests or clinical screening protocols are available.

RENAL

Renal & urinary health

Breed-associated kidney and urinary disorders, including conditions with validated molecular markers or recognised familial patterns, monitored within veterinary screening programmes.

RESP

Respiratory & functional health

Respiratory function and inherited or conformation-related risk are assessed through appropriate clinical protocols, especially where breathing efficiency affects health and welfare.

REPRO

Reproduction, fertility & neonatal outcomes

Fertility, litter outcomes, inherited reproductive problems and neonatal information contribute to long-term evaluation of breeding lines and population health.

COAT

Skin, coat & hair structure

Hereditary follicular disorders, ichthyosis-type conditions, coat structure, hair length, colour dilution alopecia and related dermatological risks.

COLOR

Colour, dilution & pattern genetics

Genetic control of pigment and coat traits, including A, B, D, E, K, M, S and other relevant loci, with attention to combinations linked to health risk.

POP

Population genetics & diversity

Parentage, DNA profiles, relatedness, inbreeding trends, carrier frequency, bottlenecks and sustainable mating strategies across generations.

Prevention & practical solutions

Research becomes useful only when it improves breeding decisions

The Institute's objective is not simply to catalogue diseases. It is to transform verified information into preventive action: identify real breed risks, choose appropriate tests, interpret them correctly, plan compatible matings and measure the results over successive generations.

01

Identify priority risks

Use breed history, veterinary evidence, pedigree information and population data to define what genuinely needs to be monitored.

02

Screen correctly

Combine validated DNA tests with imaging, clinical examinations and phenotype-based assessments when required.

03

Plan compatible matings

Reduce the probability of affected offspring without unnecessarily discarding valuable carriers or narrowing genetic diversity.

04

Follow the offspring

Health, fertility, structure, temperament and later-life information are used to verify whether selection decisions work in practice.

05

Review population trends

A.I.D.D. aggregates verified records so that policies can evolve according to measurable results rather than assumptions.

Scientific interpretation

Genetic disease is not one single category

The Institute distinguishes between simple inheritance, complex risk and phenotype-based disease so that breeding decisions are proportionate and scientifically defensible.

Monogenic disorders

Some conditions are strongly associated with a variant in a single gene. When the variant is validated for the relevant breed, DNA testing may identify genetically clear animals, carriers and affected genotypes.

Complex and polygenic conditions

Hip and elbow dysplasia are examples of conditions in which genes interact with growth, environment, nutrition and other factors. They cannot be managed through one DNA result alone and require structured phenotypic evaluation.

Penetrance and variable expression

A detected variant does not always lead to the same clinical outcome in every dog. Age of onset, severity and expression may be modified by other genes and environmental factors.

Carriers and genetic diversity

For recessive diseases, clinically healthy carriers should not automatically be removed from the population. Controlled mating with genetically clear partners can reduce disease risk while protecting valuable diversity.

Scientific principle: responsible selection is risk management, not genetic purging. Excessively eliminating dogs on the basis of a single marker can reduce diversity and create new population problems. This principle is already part of the WDF scientific project framework.
Veterinary diagnostic imaging for a dog
Orthopaedic and structural disease often requires clinical and imaging evidence in addition to genetic information.
Skeletal & structural health

From radiographic screening to multigenerational risk reduction

Skeletal disease is one of the areas where over-simplification is particularly dangerous. Hip dysplasia, elbow dysplasia and patellar luxation are important examples of conditions that are often assessed phenotypically and may be influenced by multiple biological and environmental factors. Breed-specific protocols may also include spinal disorders, chondrodystrophy and intervertebral disc disease risk, osteochondral development and other structural concerns.

  • Hip and elbow dysplasia screening
  • Patellar luxation assessment
  • Spinal and disc-related risk
  • Developmental orthopaedic conditions
  • Dentition and structural anomalies
  • Longitudinal offspring monitoring
International health databases such as OFA/CHIC emphasize that screening requirements must be tailored to the diseases of greatest concern for each breed, and that not every condition has a DNA test. Phenotypic evaluations remain essential when molecular testing is unavailable or insufficient.
Coat, colour & dermatogenetics

Colour is a genetic trait; health interpretation requires context

Coat colour and hair structure are governed by multiple genetic loci. Modern laboratories can test many of these traits, including agouti, brown, dilution, extension, merle, piebald/white spotting, coat length, curl, furnishings, shedding and other breed-specific variants. These tests help predict inheritance and document breeding combinations.

Colour itself should not automatically be treated as disease. The health question arises when particular genetic combinations are associated with increased risk. Examples include colour dilution alopecia in susceptible dogs, pigment-associated congenital deafness in some populations, and the elevated risk associated with certain double-merle combinations. Hereditary follicular dysplasias and other congenital skin or hair disorders also form part of dermatogenetic research.

Controls before colour-based selection

Aesthetic objectives must never override health, breed standard, population diversity or validated scientific evidence. Colour testing should be interpreted as one component of a broader reproductive protocol.

Laboratory partnership & services

From the biological sample to a verified genetic result

WDF relies on specialised veterinary genetics services for DNA analysis and has an agreement for genetic testing services with the LABOKLIN / LABOGEN laboratory network. Laboratory results are then connected to the dog’s identity and official record inside the WDF information system.

LABOKLIN / LABOGEN genetics services

LABOGEN is the genetics department of LABOKLIN. Its public diagnostic portfolio includes hereditary disease testing, coat colour and coat structure, DNA profiles, identity and parentage analysis and breed-related genetic combinations. LABOKLIN states that EDTA blood can be used for molecular genetic testing and that buccal swabs are also accepted for many dog tests; DNA profiling and parentage work may use laboratory-defined sample protocols.

The Institute uses these laboratory capabilities as part of a broader WDF control system. A laboratory report is not interpreted in isolation: it is linked to microchip identity, pedigree, the specific test performed, sample provenance and the reproductive or clinical context.

Veterinary examination of a dog
Veterinary examination and laboratory genetics are complementary components of responsible health screening.
1. IdentityMicrochip, pedigree and owner/breeder record.
2. SampleBlood, buccal swab or other laboratory-accepted material.
3. AnalysisValidated genetic, identity or parentage test.
4. InterpretationBreed context, phenotype, veterinary evidence and mating compatibility.
5. A.I.D.D.Verified result stored for traceability, reproduction and statistics.
WDF reproductive classifications

AR1, AR2 and NFB: a controlled breeding decision framework

These are internal WDF reproductive classifications. They are not veterinary diagnoses and must be assigned only after the applicable protocol, evidence and mating context have been evaluated.

AR1

Selected subjects meeting the highest level defined by the applicable WDF and national breed protocol, within the scope of the tests performed.

AR2

Subjects with limited or minor findings that may be considered only under documented mating restrictions and professional supervision.

NFB

Not for breeding: subjects excluded from reproduction because of serious transmissible risk, incompatibility or other disqualifying conditions.

The wording above follows the WDF internal scientific project specification. Final classification must remain linked to breed protocol, professional evidence, laboratory documentation and the compatibility of the proposed mating.
A.I.D.D. integration

From individual health records to international research data

A.I.D.D. — Artificial Intelligence Dog Database — is the WDF digital infrastructure that connects identity, pedigree, DNA deposits, health screening, reproduction, offspring and long-term population information. The scientific value comes from traceability and standardisation, not from the mere quantity of records.

ID

Genealogical continuity

Parents, ancestors, imported pedigrees and offspring remain connected when dogs move between countries.

DNA

Biological sample traceability

Sample type, date, laboratory reference and documentary status remain linked to the individual dog.

HEALTH

Standardised results

Clinical, imaging and DNA results can be compared by breed, country, generation and time period.

BREED

Reproductive controls

Restrictions, compatibility, mating, litters and offspring outcomes are connected to the health record.

POP

Variant frequency

Carrier rates, affected cases and changes in known variants can be monitored across populations.

COI

Relatedness trends

Pedigree depth and inbreeding indicators help identify bottlenecks and overuse of individual bloodlines.

QA

Data quality

Missing evidence, duplicate identifiers and unverified declarations can be separated from validated data.

R&D

Research development

Aggregated evidence supports review of breed priorities, screening coverage and the effect of breeding policies.

A.I.D.D. principle: automated controls and analytical algorithms can support detection of missing fields, improbable records, duplicate microchips, excessive relatedness or unverified claims, but they support — rather than replace — veterinarians, geneticists, laboratories and WDF scientific bodies.
Reference framework

Scientific sources used to structure this project area

The Institute follows the principle that breed-specific protocols, laboratory validation and veterinary interpretation are essential. These external resources are useful reference points for the public explanation of the project.

OFA / Canine Health Information Center

Breed-specific screening programs covering orthopaedic, eye, cardiac, patellar, thyroid and DNA-based health evaluations.

View CHIC framework
Cornell University College of Veterinary Medicine

Educational resources on canine genetic testing, inherited disease risk, parentage and the limitations of interpreting genetic findings.

Canine DNA testing
UC Davis Veterinary Genetics Laboratory

Reference material for canine coat colour genetics, dilution, merle and other inherited pigmentation traits.

Coat colour genetics
LABOKLIN / LABOGEN

Veterinary genetics services for hereditary disease testing, coat characteristics, identity, parentage and DNA profiling.

Genetics diagnostic spectrum
This page describes the institutional and scientific framework of the WDF Institute of Genetic Research and Development. It is educational and does not replace veterinary diagnosis, specialist interpretation, laboratory advice, national legislation or breed-specific professional protocols. Genetic and reproductive decisions must be based on verified evidence and competent professional assessment.